Alaunos Therapeutics, Inc. (TCRT) Q3 2022 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, and thank you for standing by. Welcome to the Alana's Therapeutics third quarter 2022 financial results conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during this session, you'll need to press star 1 1 on your telephone. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Alex Lobo, with Stern Investor Relations. Please go ahead. Thank you. Good morning, and welcome to the Alanos Therapeutics third quarter 2022 financial results conference call and audio webcast. Please note that today's webcast contains slides, which are available through the audio webcasting platform. A copy of the presentation will be available on our website after today's call. Earlier this morning, Alanos issued a press release announcing financial results for the three months ended September 30th, 2022. We encourage everyone to read today's press release, as well as the Alanos quarterly report on Form 10-Q for the quarter ended September 30th, 2022, which was filed this morning with the SEC. The company's press release and quarterly report will also be available on the Alanos website at alanos.com. In addition, this conference call is being webcast through the investor relations section of the company's website and will be archived there for future reference. Please note that certain information discussed on today's call covered under the safe harbor provisions of the private securities litigation reform act of 1995. Participants are cautioned that this conference call contains time sensitive information that is accurate only as of the date of this live broadcast, November 14th, 2022. A...